Evidence map›Paper›PMID 42328908›Full record

ArticleArthritis care & research2026

Assessing Reliability of an Electronic Gout Flare Assessment Protocol.

Shravani Chitineni, Daniel H Solomon, Hyon Choi, Ana D Fernandes, Shreya Billa, Kiara Tan, Chio Yokose, Michael J Barry, Misti L Paudel

Abstract read
In one paragraph

Article in Arthritis care & research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shravani ChitineniBrigham and Women's Hospital, Boston, Massachusetts.ORCID https://orcid.org/0009-0009-7641-3024
Daniel H SolomonBrigham and Women's Hospital, Boston, Massachusetts.
Hyon ChoiHarvard Medical School, Boston, Massachusetts.
Ana D FernandesMassachusetts General Hospital, Boston, Massachusetts.
Shreya BillaBrigham and Women's Hospital, Boston, Massachusetts.
Kiara TanMassachusetts General Hospital, Boston, Massachusetts.
Chio YokoseHarvard Medical School, Boston, Massachusetts.ORCID https://orcid.org/0000-0001-7557-3303
Michael J BarryHarvard Medical School, Boston, Massachusetts.
Misti L PaudelBrigham and Women's Hospital, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-8361-0650

Funding

Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)U01AR080985 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MICHAEL J BARRY, HYON K CHOI · 2023 to 2026
$7.7M
NIAMS NIH HHS U01 AR080985NIAMS NIH HHS U01AR080985
6 · The paper itself

Abstract

objectiveMost trials in gout focus on serum urate changes because assessing gout flares is difficult. We evaluated the reliability of an electronic, self-reported gout flare assessment compared to a staff-conducted telephone questionnaire.

methodsA convenience sample of participants from the Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout (TRUST) randomized clinical trial, which examines gout flares as a primary outcome, completed biweekly electronic surveys reporting gout flares. Study staff blinded to treatment assignment conducted a gout flare assessment at standard biweekly telephone visits to confirm electronic reports. We assessed agreement between flare assessment modalities using multiple assessments such as percent agreement, Cohen's kappa, Gwen's AC1 statistic, McNemar's test of equivalence, and intraclass correlation coefficient (ICC). In addition, we accounted for repeated measures within patients using mixed effects models, presenting a mixed effects ICC. Where necessary, 95% confidence intervals were calculated using nonparametric bootstrapping.

resultsA total of 28 patients (mean age 60.5 years, SD 13; 93% male) participated in the 12-week pilot, completing 109 flare periods with 108 electronic and 99 phone assessments. Patients reported 23 flares on electronic surveys and 22 flares on phone surveys. We observed a raw percent agreement between survey types of 96%. All measures of agreement consistently demonstrated strong concordance, with an ICC of 0.880 and a mixed effects ICC of 0.746.

conclusionThe pilot study shows strong agreement between electronic and telephone gout flare assessments across multiple equivalence tests, supporting electronic surveys as an accurate and efficient alternative to phone assessments.

Identifiers

PMID42328908
PMCPMC13373963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.